Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion type Assertion NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_head.
- NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion wasGeneratedBy ECO_0000203 NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_provenance.
- NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion wasDerivedFrom befree-20140225 NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_provenance.
- NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion SIO_000772 23070117 NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_provenance.
- NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion evidence source_evidence_literature NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_provenance.
- NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_assertion description "[Erythropoietin-producing hepatocellular carcinoma A2 (EphA2) has emerged as an attractive target for the immunotherapy of GBM as it is overexpressed in glioma and promotes its malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326757.RAr1EwyBWNjAMlRENmVw2yNnNDzjC2iQ48k8Nm5TohFos130_provenance.